Figure 2.
Exosomal miRNAs (a) and serum miRNAs (b) extracted from healthy control (HC) individuals and multiple myeloma (MM) patients. The expression levels of different miRNAs were measured by real-time quantitative PCR, and the relative gene expression levels were normalized based on spike-in control Cel-miR-39. The results were calculated by the 2−ΔΔCT method. ∗The serum exosomal miRNA expression levels were decreased in MM patients compared with those in the HC group (p < 0.05). Values are expressed as the mean ± SD.
